Age-Dependent Neurodegeneration Accompanying Memory Loss in Transgenic Mice Defective in Mitochondrial Aldehyde Dehydrogenase 2 Activity
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Oxidative stress may underlie age-dependent memory loss and cognitive decline. Toxic aldehydes, including 4-hydroxy-2-nonenal (HNE), an end product of lipid peroxides, are known to accumulate in the brain in neurodegenerative disease. We have previously shown that mitochondrial aldehyde dehydrogenase 2 (ALDH2) detoxifies HNE by oxidizing its aldehyde group. To investigate the role of such toxic aldehydes, we produced transgenic mice, which expressed a dominant-negative form of ALDH2 in the brain. The mice had decreased ability to detoxify HNE in their cortical neurons and accelerated accumulation of HNE in the brain. Consequently, their lifespan was shortened and age-dependent neurodegeneration and hyperphosphorylation of tau were observed. Object recognition and Morris water maze tests revealed that the onset of cognitive impairment correlated with the degeneration, which was further accelerated by APOE (apolipoprotein E) knock-out; therefore, the accumulation of toxic aldehydes is by itself critical in the progression of neurodegenerative disease, which could be suppressed by ALDH2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 1×
“A decline in cognitive function is associated with aging, mainly as a result of oxidative stress in the brain (Mattson, 2004).”
Background4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164 · cited 1×
“In particular, HNE is a strong electrophile and has the ability to readily adduct and damage proteins (Uchida, 2003).”
BackgroundImmunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981 · cited 1×
“The accumulation of HNE-adducted proteins in pyramidal neurons has been observed in the brains of patients with Alzheimer’s disease (AD) and Parkinson’s disease (Yoritaka et al., 1996; Lovell et al., 1997; Montine et al., 1997; Sayre et al., 1997).”
BackgroundMark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551 · cited 1×
“…changes noted in AD, including modification of tau (Takeda et al., 2000; Liu et al., 2005) and -amyloid (Murray et al., 2007), inhibition of the glucose transporter (Reagan et al., 2000), and microtubular disruption (Gadoni et al., 1993), and eventually leads to cell death (Mark et al., 1997).”
BackgroundEarly embryonic lethality caused by targeted disruption of the mouse PHGPx gene
Imai, H., Hirao, F., Sakamoto, T., Sekine, K., Mizukura, Y., Saito, M., Kitamoto, T., Hayasaka, M., Hanaoka, K., & Nakagawa, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00734-4 · Cited by 357
Two Distinct Pathways of Formation of 4-Hydroxynonenal
Schneider, C., Tallman, K. A., Porter, N. A., & Brash, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101821200 · Cited by 313
Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP
Wang, H., Ferguson, G. D., Pineda, V. V., Cundiff, P. E., & Storm, D. R. (2004) · Nature Neuroscience · doi:10.1038/nn1248 · Cited by 244 · cited 1×
“The visual object recognition test (vORT) was used to test recognition memory (Wang et al., 2004).”
MethodMitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene
Esposito, L. A., Kokoszka, J. E., Waymire, K. G., Cottrell, B., MacGregor, G. R., & Wallace, D. C. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00161-1 · Cited by 228 · cited 2×
“…peroxidase, and catalase developed normally and showed no marked pathological changes under normal physiological conditions (Reaume et al., 1996; Esposito et al., 2000; Ho et al., 2004), indicating that their defects in major antioxidant defense mechanisms are strongly compensated by each other.”
BackgroundAdenylyl cyclase type 5 (AC5) is an essential mediator of morphine action
Kim, K.-S., Lee, K.-W., Lee, K.-W., Im, J.-Y., Yoo, J. Y., Kim, S.-W., Lee, J.-K., Nestler, E. J., & Han, P.-L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508812103 · Cited by 123 · cited 1×
“Locomotor activity was measured using an open-field apparatus (45 45 65 cm) (Kim et al., 2006).”
Method
Cited by
Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities
Chen, C.-H., Ferreira, J. C. B., Gross, E. R., & Mochly-Rosen, D. (2014) · Physiological Reviews · doi:10.1152/physrev.00017.2013 · Cited by 614
Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration
Musiek, E. S., Lim, M. M., Yang, G., Bauer, A. Q., Qi, L., Lee, Y., Roh, J. H., Ortiz-Gonzalez, X., Dearborn, J. T., Culver, J. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70317 · Cited by 524
Ohta, S. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797052664 · Cited by 296
Self-citationNagata, K., Nakashima-Kamimura, N., Mikami, T., Ohsawa, I., & Ohta, S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.95 · Cited by 271
Self-citationLoPachin, R. M., Gavin, T., Petersen, D. R., & Barber, D. S. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900147g · Cited by 266
Metadata
- Authors
- Ohsawa, I., Nishimaki, K., Murakami, Y., Suzuki, Y., Ishikawa, M., & Ohta, S.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-06-11
- Volume
- 28
- Issue
- 24
- Pages
- 6239-6249
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2015032101
- Cited by
- 117
- References
- 9
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.